Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey

Andrea Lombardi, Marta Colaneri, Margherita Sambo, Angela Di Matteo, Paolo Sacchi, Massimiliano Fabbiani, Luigi Codecasa, Stefano Aliberti, Francesco Blasi, Alessandra Bandera, Raffaele Bruno, Andrea Gori

Research output: Contribution to journalArticlepeer-review

Abstract

The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investigated the clinical features associated with starting an antimicrobial treatment in patients with nontuberculous mycobacterial lung disease among Italian physicians involved in the field. We found that in real life predictors of starting antimicrobial treatment are quite adherent to international guidelines, with some uncertainties regarding the implication of immunosuppressive drugs.

Original languageEnglish
Article number106341
JournalRespiratory Medicine
Volume179
DOIs
Publication statusPublished - Apr 2021

Keywords

  • Antimycobacterial treatment
  • Clinical management
  • Lung disease
  • Nontuberculous mycobacteria

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey'. Together they form a unique fingerprint.

Cite this